Myeloproliferative neoplasms: Morphology and clinical practice

被引：33

作者：

Barbui, Tiziano ^{[1
]}

Thiele, Juergen ^{[2
]}

Vannucchi, Alessandro M. ^{[3
]}

Tefferi, Ayalew ^{[4
]}

机构：

[1] Papa Giovanni XXIII Hosp, Res Fdn, Bergamo, Italy

[2] Univ Cologne, Inst Pathol, Joseph Stelzmann Str 9, Cologne, Germany

[3] Univ Florence, Dept Expt & Clin Med, Florence, Italy

[4] Mayo Clin, Div Hematol, Rochester, MN USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 04期

关键词：

BONE-MARROW FIBROSIS; CHRONIC IDIOPATHIC MYELOFIBROSIS; INTERNATIONAL WORKING GROUP; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; REFRACTORY-ANEMIA; RINGED SIDEROBLASTS; DIAGNOSTIC-CRITERIA; HISTOLOGICAL CRITERIA; BLAST-TRANSFORMATION;

D O I：

10.1002/ajh.24288

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducibility of bone marrow (BM) features. Disagreements concerning the WHO classification are mainly focused on the discrimination between essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis (prePMF) and prodromal polycythemia vera (PV). Criticism mostly refers to lack of standardization of distinctive BM features precluding correct morphological pattern recognition. The distinction between WHO-defined ET and prePMF is not trivial because outcome is significantly worse in prePMF. Morphology was generally considered to be non-specific for the diagnosis of PV. Recent studies have revealed under-diagnosis of morphologically and biologically consistent PV. Am. J. Hematol. 91:430-433, 2016. (c) 2015 Wiley Periodicals, Inc.

引用

收藏

页码：430 / 433

页数：4

相关论文

共 74 条

[31] Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis [J].

Jamieson, Catriona ;

Hasserjian, Robert ;

Gotlib, Jason ;

Cortes, Jorge ;

Stone, Richard ;

Talpaz, Moshe ;

Thiele, Juergen ;

Rodig, Scott ;

Pozdnyakova, Olga .

JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13

[32] The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis:: A retrospective evaluation of sequential bone marrow biopsies [J].

Kreft, A ;

Büsche, G ;

Ghalibafian, M ;

Buhr, T ;

Fischer, T ;

Kirkpatrick, CJ .

ACTA HAEMATOLOGICA, 2005, 113 (02) :137-143

[33] Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis [J].

Kroeger, Nicolaus ;

Thiele, Eirgen ;

Zander, Axel ;

Schwerdtfeger, Rainer ;

Kobbe, Guido ;

Bornhaeuser, Martin ;

Bethge, Wolfgang ;

Schubert, Jorg ;

de Witte, Theo ;

Kvasnicka, Hans Michael .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) :1719-1722

[34] The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera [J].

Kvasnicka, Hans Michael ;

Thiele, Juergen .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04) :362-371

[35] Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study [J].

Kvasnicka, Hans Michael ;

Beham-Schmid, Christine ;

Bob, Roshanak ;

Dirnhofer, Stephan ;

Hussein, Kais ;

Kreipe, Hans ;

Kremer, Marcus ;

Schmitt-Graeff, Annette ;

Schwarz, Stephan ;

Thiele, Juergen ;

Werner, Martin ;

Stein, Harald .

HISTOPATHOLOGY, 2016, 68 (06) :905-915

[36] WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update [J].

Kvasnicka, Hans Michael .

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) :333-341

[37] Prodromal myeloproliferative neoplasms: The 2008 WHO classification [J].

Kvasnicka, Hans Michael ;

Thiele, Juergen .

AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (01) :62-69

[38] A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera [J].

Lussana, Federico ;

Carobbio, Alessandra ;

Randi, Maria L. ;

Elena, Chiara ;

Rumi, Elisa ;

Finazzi, Guido ;

Bertozzi, Irene ;

Pieri, Lisa ;

Ruggeri, Marco ;

Palandri, Francesca ;

Polverelli, Nicola ;

Elli, Elena ;

Tieghi, Alessia ;

Iurlo, Alessandra ;

Ruella, Marco ;

Cazzola, Mario ;

Rambaldi, Alessandro ;

Vannucchi, Alessandro M. ;

Barbui, Tiziano .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) :541-546

[39] WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect - the Danish experience [J].

Madelung, Ann B. ;

Bondo, Henrik ;

Stamp, Inger ;

Lovgreen, Preben ;

Nielsen, Signe L. ;

Falensteen, Anne ;

Knudsen, Helle ;

Svendsen, Kira D. ;

Lange, Theis ;

Ralfkiaer, Elisabeth ;

Nielsen, Karsten ;

Hasselbalch, Hans ;

Thiele, Juergen .

APMIS, 2015, 123 (09) :787-792

[40] World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-The Danish experience [J].

Madelung, Ann Brinch ;

Bondo, Henrik ;

Stamp, Inger ;

Loevgreen, Preben ;

Nielsen, Signe Ledou ;

Falensteen, Anne ;

Knudsen, Helle ;

Ehinger, Mats ;

Dahl-Sorensen, Rasmus ;

Mortensen, Nana Brochmann ;

Svendsen, Kira Dynnes ;

Lange, Theis ;

Ralfkiaer, Elisabeth ;

Nielsen, Karsten ;

Hasselbalch, Hans Carl ;

Thiele, Juergen .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (12) :1012-1016

← 1 2 3 4 5 6 7 8 →